Abstract
1. Crystallized soy bean trypsin inhibitor, at a concentration of 100 µg./ml., suppressed the production of thrombin from a mixture of prothrombin and blood thrombokinase. The experiment was performed in the presence of 0.011 M oxalate, in order to minimize the possibility of participation by accessory factors which require ionic calcium. The results are in accord with the view that thrombokinase is a trypsin-like enzyme. 2. When a solution of blood thrombokinase was centrifuged at 85,000 g for 120 minutes, almost all the activity remained in the supernate. This supernate activated the supernate from a prothrombin solution which had been similarly centrifuged. The activation of prothrombin by thrombokinase can proceed in the absence of material completely sedimentable in 120 minutes at 85,000 g. 3. An "accelerator" reagent was prepared by treating bovine serum with barium carbonate, and then passing the serum through a column of diatomaceous earth. This "accelerator" was used together with prothrombin, blood thrombokinase, Howell's cephalin, and calcium chloride to compose a five-reagent thrombin-producing system. In this system, no thrombin was produced without thrombokinase. On the other hand, thrombin was produced from prothrombin and thrombokinase, even when all the other reagents were omitted. When calcium was omitted, thrombokinase was able to function; but cephalin and the "accelerator" reagent were ineffective. 4. Quantitative tests indicated that the "accelerator" reagent exerted an effect distinct from those of thrombokinase and cephalin. However, it is not certain whether the "accelerator" reagent functioned as an accessory factor, as a potential source of more thrombokinase, or both. In the experiments reported, thrombokinase was primary to, or necessary for, the effect of "accelerator." 5. The effectiveness of thrombokinase was multiplied a hundred times or more, when complemented by calcium, cephalin, and "accelerator" reagent. Ionic calcium was a necessary component of this complementing system. This may help to explain why removal of calcium ions keeps blood fluid, even though thrombokinase, by itself, is little influenced either by calcium ions or by oxalate.
Full Text
The Full Text of this article is available as a PDF (737.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALEXANDER B., GOLDSTEIN R., LANDWEHR G. The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin. J Clin Invest. 1950 Jul;29(7):881–895. doi: 10.1172/JCI102322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collingwood B. J., Macmahon M. T. The anti-coagulants in blood and serum. J Physiol. 1912 Sep 11;45(3):119–145. doi: 10.1113/jphysiol.1912.sp001541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glazko A. J. EFFECT OF BLOOD PROTEASE AND TRYPSIN INHIBITOR ON THE CLOTTING MECHANISM. J Clin Invest. 1947 May;26(3):364–369. doi: 10.1172/JCI101818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JENSEN H., GRAY E. J., SCHAEFER E. H., Jr Heat stability studies on clotting factors in thromboplastic preparations. Proc Soc Exp Biol Med. 1954 Jun;86(2):387–390. doi: 10.3181/00379727-86-21108. [DOI] [PubMed] [Google Scholar]
- JOHNSON S. A., SMATHERS W. M., SCHNEIDER C. L. Platelets and their plasma cofactor activity in the activation of purified prothrombin. Am J Physiol. 1952 Sep;170(3):631–635. doi: 10.1152/ajplegacy.1952.170.3.631. [DOI] [PubMed] [Google Scholar]
- MILSTONE J. H. A highly active material that promotes conversion of prothrombokinase complex. Proc Soc Exp Biol Med. 1949 Nov;72(2):315–315. doi: 10.3181/00379727-72-17419. [DOI] [PubMed] [Google Scholar]
- MILSTONE J. H. Chromatography of blood-clotting factors and serum proteins on columns of diatomaceous earth. J Gen Physiol. 1955 Jul 20;38(6):743–755. doi: 10.1085/jgp.38.6.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MILSTONE J. H., MILSTONE V. K. Failure of lipoid thromboplastin to act as cofactor for trypsin in the activation of proenzymes. Yale J Biol Med. 1954 Feb;26(4):307–312. [PMC free article] [PubMed] [Google Scholar]
- MILSTONE J. H. On the evolution of blood clotting theory. Medicine (Baltimore) 1952 Dec;31(4):411–447. doi: 10.1097/00005792-195212000-00004. [DOI] [PubMed] [Google Scholar]
- Macfarlane R. G. The action of soya-bean trypsin inhibitor as an anti-thromboplastin in blood coagulation. J Physiol. 1947 Mar 15;106(1):104–111. [PMC free article] [PubMed] [Google Scholar]
- Milstone J. H. Prothrombokinase and the Three Stages of Blood Coagulation. Science. 1947 Dec 5;106(2762):546–547. doi: 10.1126/science.106.2762.546-a. [DOI] [PubMed] [Google Scholar]
- OWREN P. A. La proconvertine. Rev Hematol. 1952;7(2):147–155. [PubMed] [Google Scholar]
- TRAVIS B. L., FERGUSON J. H. Proteolytic enzymes and platelets in relation to blood coagulation. J Clin Invest. 1951 Jan;30(1):112–123. doi: 10.1172/JCI102411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WARE A. G., SEEGERS W. H. Two-stage procedure for the quantitative determination of prothrombin concentration. Am J Clin Pathol. 1949 May;19(5):471–482. [PubMed] [Google Scholar]